Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brobeil, A.
Right arrow Articles by Reintgen, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brobeil, A.
Right arrow Articles by Reintgen, D. S.

Annals of Surgical Oncology, Vol 5, Issue 4 376-383, Copyright © 1998 by Society of Surgical Oncology

ARTICLES

Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma

A. Brobeil, C. Berman, C. W. Cruse, R. De Conti, A. Cantor, G. H. Lyman, E. Joseph, D. Rapaport, K. Wells and D. S. Reintgen
Cutaneous Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa 33612-9497, USA.

BACKGROUND: Recurrent melanoma of the extremity has been treated by local excision, systemic chemotherapy, amputation, or a combination of these approaches. Hyperthermic isolated limb perfusion (HILP) provides a method of limb preservation through isolation, allowing the administration of chemotherapy in higher doses than is possible through systemic treatment. METHODS: An experimental group of 59 HILP patients with melanoma recurrences of the extremity was studied prospectively. A control group of 248 melanoma patients with similar recurrences was excluded from HILP because their recurrences were in non-extremity locations. The experimental group underwent HILP and excision; the control group had excision only. The experimental procedure consisted of vascular isolation of the affected extremity and a 1-hour perfusion with melphalan. Temperatures were maintained at 40 degrees C in the perfusion circuit. RESULTS: The HILP patients had a lower rate of locoregional recurrence (P=.028) and demonstrated increased survival (P=.026) compared to the control group. In multivariate regression analysis, which included age, ulceration and thickness of the primary, and the treatment variable of perfusion, age (P=.02) and perfusion for the treatment of recurrence (P=.006) were significant predictors of survival. CONCLUSIONS: HILP improves prognosis by sterilizing the treated extremity, controlling locoregional disease, and perhaps preventing metastasis, thus having a positive impact on overall survival.


This article has been cited by other articles:


Home page
 Arch SurgHome page
T. A. Aloia, E. Grubbs, M. Onaitis, P. J. Mosca, T.-Y. Cheng, H. Seigler, and D. S. Tyler
Predictors of Outcome After Hyperthermic Isolated Limb Perfusion: Role of Tumor Response
Arch Surg, November 1, 2005; 140(11): 1115 - 1120.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. B. Zwischenberger, R. A. Vertrees, E. A. Bedell, C. K. McQuitty, J. M. Chernin, and L. C. Woodson
Percutaneous venovenous Perfusion-Induced systemic hyperthermia for lung cancer: a phase I safety study
Ann. Thorac. Surg., June 1, 2004; 77(6): 1916 - 1925.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. B. Zwischenberger, R. A. Vertrees, L. C. Woodson, E. A. Bedell, S. K. Alpard, C. K. McQuitty, and J. M. Chernin
Percutaneous venovenous perfusion-induced systemic hyperthermia for advanced non-small cell lung cancer: initial clinical experience
Ann. Thorac. Surg., July 1, 2001; 72(1): 234 - 242.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society of Surgical Oncology.